BRIAN GAYNOR: ASX investors want our growth companies

BRIAN GAYNOR: ASX investors want our growth companies
Aroa ceo Brian Ward rings the bell at listing on the ASX in June
Brian Gaynor
Ryman Healthcare shareholders were taken aback this week by a couple of short replies to the following question: “Does the company intend to seek a listing on the ASX?”.Chief executive Gordon MacLeod answered “No” while chairman David Kerr told annual meeting attendees: “Not at this time. We have contemplated dual listing but we are not – that’s not an active discussion at the moment.”Why is Ryman unenthusiastic about an NZX/ASX dual listing when 14 of the largest 20 NZX companies are also listed...

More Opinion

Is innovation a priority for National?
Opinion

Peter Griffin: Is innovation a priority for National?

The challenge for Shane Reti will be to chart a new course in science and innovation.

Reflections on NZ's cleantech
Opinion

Phil Anderson: Reflections on NZ's cleantech

Building a NZ cleantech company from scratch starts with being there.

Phil Anderson 22 Jan 2025
First there was Word, then came inflation
Finance

David Chaplin: First there was Word, then came inflation

The Reserve Bank thinks it has tamed the beast – but costs are still rising. 

David Chaplin 22 Jan 2025
The cost of climate inaction
Opinion

Dileepa Fonseka: The cost of climate inaction

Doing nothing will likely cost NZ more than taking action ever will.

Dileepa Fonseka 20 Jan 2025